Onward Medical N.V. (ONWRF)
OTCMKTS · Delayed Price · Currency is USD
5.05
-0.55 (-9.82%)
At close: Feb 2, 2026

Onward Medical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
222239103201350-
Market Cap Growth
-22.18%131.41%-48.45%-42.70%--
Enterprise Value
19122473133416-
Last Close Price
5.056.003.79---
PS Ratio
69.65132.94175.8987.41220.07-
PB Ratio
6.824.815.223.573.72-
P/TBV Ratio
10.246.1411.514.424.24-
EV/Sales Ratio
59.41124.46123.3858.14261.77-
Debt / Equity Ratio
0.540.310.940.270.17-1.31
Net Debt / Equity Ratio
-0.93-0.94-0.72-0.90-0.92-1.11
Net Debt / EBITDA Ratio
0.731.300.371.492.67-2.32
Net Debt / FCF Ratio
0.721.410.391.753.80-2.72
Asset Turnover
0.050.030.010.020.020.04
Quick Ratio
3.926.574.527.6616.372.45
Current Ratio
4.346.854.707.8116.672.62
Return on Equity (ROE)
-167.80%-108.28%-102.55%-48.44%-135.66%-
Return on Assets (ROA)
-43.66%-36.37%-36.87%-22.07%-29.97%-51.66%
Return on Capital Employed (ROCE)
-78.50%-52.10%-96.00%-46.80%-28.70%-134.60%
Earnings Yield
-20.43%-15.45%-38.67%-17.46%-11.14%-
FCF Yield
-19.09%-13.80%-34.94%-14.42%-6.49%-
Buyback Yield / Dilution
-53.03%-47.86%--218.23%-163.40%-19.35%
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.